1,720,994 research outputs found
Association of gender and age with erythropoietin resistance in hemodialysis patients: role of menstrual status
No full textSleep disorders in kidney disease
No full textSleep disorders are common in patients with end stage renal disease receiving hemodialysis or peritoneal dialysis. However also a well functioning renal graft does not cure the poor sleep pattern which now emerges as a problem even in early chronic kidney disease (CKD). When patients are made aware for the first time of a disease such as CKD, which may brink to dialysis or at the best to a renal transplant patients begin to experience a disordered sleep. Sleeping disorders include insomnia (I), sleep apnoea (SAS), restless legs syndrome (RLS), periodic limb movement disorder (PLMD), excessive daily sleeping (EDS), sleepwalking, nightmares, and narcolepsy. Disordered sleep did not meet the clinical and scientific interest it deserves, in addition and we do not have a well defined solution for sleeping complaints. However, awareness that a poor sleep is associated with poor quality of life and carries an increase in mortality risk has recently stimulated interest in the field. There are many putative causes for a disordered sleep in chronic kidney disease and in end-stage renal disease. For a unifying hypothesis demographic factors, lifestyles, disease related factors, psychological factors, treatment related factors, and social factor must be taken into consideration
Sleep disorders in kidney disease.
No full textSleep disorders are common in patients with end stage renal disease receiving hemodialysis or peritoneal dialysis. However also a well functioning renal graft does not cure the poor sleep pattern which now emerges as a problem even in early chronic kidney disease (CKD). When patients are made aware for the first time of a disease such as CKD, which may brink to dialysis or at the best to a renal transplant patients begin to experience a disordered sleep. Sleeping disorders include insomnia (I), sleep apnoea (SAS), restless legs syndrome (RLS), periodic limb movement disorder (PLMD), excessive daily sleeping (EDS), sleepwalking, nightmares, and narcolepsy. Disordered sleep did not meet the clinical and scientific interest it deserves, in addition and we do not have a well defined solution for sleeping complaints. However, awareness that a poor sleep is associated with poor quality of life and carries an increase in mortality risk has recently stimulated interest in the field. There are many putative causes for a disordered sleep in chronic kidney disease and in end-stage renal disease. For a unifying hypothesis demographic factors, lifestyles, disease related factors, psychological factors, treatment related factors, and social factor must be taken into consideratio
Daily nutrient intake represents a modifiable determinant of nutritional status in chronic haemodialysis patients
No full text
Impact of BMI on Cardiovascular Events, Renal Function, and Coronary Artery Calcification.
No full textBackground/Aims: High BMI increases the risk of cardiovascular
events (CVEs) in the general population. Conflicting results
have been reported on the role of BMI on CVEs and on
decline of renal function in patients with chronic kidney disease
(CKD) not on dialysis. This study evaluates the impact of
BMI on CVEs, dialysis initiation, and coronary artery calcification
(CAC) in CKD patients. Methods: CKD patients were divided
in normal-BMI and high-BMI patients. CVEs, initiation of
dialysis, and extent and progression of CAC were assessed.
Univariate and multivariate analysis were performed (adjustment
variables: age, diabetes, hypertension, gender, CKD
stage, serum concentration of hemoglobin, parathyroid hormone,
calcium, phosphorus, albumin, C-reactive protein, LDL-cholesterol, total calcium score, 24-hour proteinuria). Patients
were followed to the first event (CVE, dialysis) or for
2 years. Results: 471 patients were evaluated. A CVE occurred
in 13.5 and 21.3% (p < 0.05) of normal-BMI and high-BMI patients,
respectively. High BMI did not increase the risk for CVEs
in univariate (HR: 1.86; 95% CI: 0.97–3.54; p = 0.06) or multivariable
analysis (HR: 1.36; 95% CI: 0.57–3.14; p = 0.50). High
BMI did not increase the risk for initiation of dialysis in univariate
(HR: 0.96; 95% CI: 0.58–1.60; p = 0.9) or multivariable
analysis (HR: 1.77; 95% CI: 0.82–3.81; p = 0.14). Adding the
interaction term (between BMI and glomerular filtration rate)
to other variables, the risk of dialysis initiation significantly
increased (HR: 3.06; 95% CI: 1.31–7.18; p = 0.01) in high-BMI
patients. High BMI was not a predictor of CAC extent or progression.
Conclusions: High BMI was not a predictor of CVEs.
High BMI increased the risk for dialysis initiation, but high BMI
was not associated to CAC extent and progression. The presence
of confounders may underestimate the impact of high
BMI on dialysis initiation
Effetti della concentrazione di sodio nel dialisato sul rebound post-dialitico del potassio
No full textInfluence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients
No full text- …
